Aethlon Medical Stock Current Valuation
AEMD Stock | USD 1.68 0.03 1.75% |
Valuation analysis of Aethlon Medical helps investors to measure Aethlon Medical's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. The current year's Enterprise Value Multiple is expected to grow to 0.44. Fundamental drivers impacting Aethlon Medical's valuation include:
Price Book 0.5784 | Enterprise Value -2.6 M | Enterprise Value Ebitda 0.2085 | Price Sales 7.6662 | Forward PE 0.2102 |
Undervalued
Today
Please note that Aethlon Medical's price fluctuation is not too volatile at this time. Calculation of the real value of Aethlon Medical is based on 3 months time horizon. Increasing Aethlon Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Aethlon Medical is useful when determining the fair value of the Aethlon stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Aethlon Medical. Since Aethlon Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Aethlon Stock. However, Aethlon Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 1.68 | Real 17.47 | Target 65.0 | Hype 1.7 | Naive 1.69 |
The real value of Aethlon Stock, also known as its intrinsic value, is the underlying worth of Aethlon Medical Company, which is reflected in its stock price. It is based on Aethlon Medical's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Aethlon Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Aethlon Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Aethlon Medical helps investors to forecast how Aethlon stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Aethlon Medical more accurately as focusing exclusively on Aethlon Medical's fundamentals will not take into account other important factors: Aethlon Current Valuation Analysis
Aethlon Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Aethlon Medical Current Valuation | (2.56 M) |
Most of Aethlon Medical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aethlon Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Aethlon Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Aethlon Medical is extremely important. It helps to project a fair market value of Aethlon Stock properly, considering its historical fundamentals such as Current Valuation. Since Aethlon Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Aethlon Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Aethlon Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition |
In accordance with the recently published financial statements, Aethlon Medical has a Current Valuation of (2.56 Million). This is 100.02% lower than that of the Health Care Equipment & Supplies sector and 100.02% lower than that of the Health Care industry. The current valuation for all United States stocks is 100.02% higher than that of the company.
Aethlon Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aethlon Medical's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aethlon Medical could also be used in its relative valuation, which is a method of valuing Aethlon Medical by comparing valuation metrics of similar companies.Aethlon Medical is currently under evaluation in current valuation category among related companies.
Aethlon Fundamentals
Return On Equity | -0.98 | ||||
Return On Asset | -0.47 | ||||
Operating Margin | (20.47) % | ||||
Current Valuation | (2.56 M) | ||||
Shares Outstanding | 2.62 M | ||||
Shares Owned By Insiders | 1.58 % | ||||
Shares Owned By Institutions | 2.12 % | ||||
Number Of Shares Shorted | 9.9 K | ||||
Price To Earning | (1.14) X | ||||
Price To Book | 0.58 X | ||||
Price To Sales | 7.67 X | ||||
Revenue | 574.25 K | ||||
Gross Profit | 574.25 K | ||||
EBITDA | (11.76 M) | ||||
Net Income | (12.03 M) | ||||
Cash And Equivalents | 14.92 M | ||||
Cash Per Share | 0.65 X | ||||
Total Debt | 1.21 M | ||||
Debt To Equity | 0.05 % | ||||
Current Ratio | 9.66 X | ||||
Book Value Per Share | 2.93 X | ||||
Cash Flow From Operations | (10.51 M) | ||||
Short Ratio | 1.34 X | ||||
Earnings Per Share | (5.01) X | ||||
Target Price | 25.0 | ||||
Number Of Employees | 15 | ||||
Beta | 1.9 | ||||
Market Capitalization | 4.4 M | ||||
Total Asset | 17.51 M | ||||
Retained Earnings | (142.36 M) | ||||
Working Capital | 13.59 M | ||||
Current Asset | 817 K | ||||
Current Liabilities | 1.08 M | ||||
Z Score | -10.45 | ||||
Net Asset | 17.51 M |
About Aethlon Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aethlon Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aethlon Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aethlon Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company was founded in 1999 and is based in San Diego, California. Aethlon Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 14 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Aethlon Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Aethlon Medical's short interest history, or implied volatility extrapolated from Aethlon Medical options trading.
Pair Trading with Aethlon Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aethlon Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aethlon Medical will appreciate offsetting losses from the drop in the long position's value.Moving together with Aethlon Stock
0.66 | MBOT | Microbot Medical Earnings Call Today | PairCorr |
0.75 | NEOG | Neogen Report 4th of April 2024 | PairCorr |
Moving against Aethlon Stock
0.9 | BSX | Boston Scientific Corp Financial Report 24th of April 2024 | PairCorr |
0.72 | PNTG | Pennant Group Financial Report 2nd of May 2024 | PairCorr |
0.67 | CLVRW | Clever Leaves Holdings | PairCorr |
0.65 | RDNT | RadNet Inc Financial Report 14th of May 2024 | PairCorr |
0.55 | SNDA | Sonida Senior Living Report 4th of April 2024 | PairCorr |
The ability to find closely correlated positions to Aethlon Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aethlon Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aethlon Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aethlon Medical to buy it.
The correlation of Aethlon Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aethlon Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aethlon Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aethlon Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Aethlon Medical Piotroski F Score and Aethlon Medical Altman Z Score analysis. For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Complementary Tools for Aethlon Stock analysis
When running Aethlon Medical's price analysis, check to measure Aethlon Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aethlon Medical is operating at the current time. Most of Aethlon Medical's value examination focuses on studying past and present price action to predict the probability of Aethlon Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aethlon Medical's price. Additionally, you may evaluate how the addition of Aethlon Medical to your portfolios can decrease your overall portfolio volatility.
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |
Is Aethlon Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aethlon Medical. If investors know Aethlon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aethlon Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.01) | Revenue Per Share 0.236 | Quarterly Revenue Growth 42.782 | Return On Assets (0.47) | Return On Equity (0.98) |
The market value of Aethlon Medical is measured differently than its book value, which is the value of Aethlon that is recorded on the company's balance sheet. Investors also form their own opinion of Aethlon Medical's value that differs from its market value or its book value, called intrinsic value, which is Aethlon Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aethlon Medical's market value can be influenced by many factors that don't directly affect Aethlon Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aethlon Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aethlon Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aethlon Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.